Related Experiment Video
Updated: May 7, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Genomic damage in patients with type-2 diabetes mellitus
D N Binici1, A Karaman, M Coşkun
1Department of Internal Medicine, Erzurum Training and Research Hospital, Erzurum, Turkey.
Abstract:
DNA damage seems to play a role in the pathogenesis of type-2 diabetes mellitus (DM2) and its complications. Several in vitro assays have been used to measure the DNA damage. In the present study, we aimed to investigate the frequency of sister chromatid exchange (SCE) and micronuclei (MN) in DM2 patients compared with healthy controls. SCE and MN tests were carried out with the blood-cell cultures from 50 DM2 patients and 30 healthy, age- and sex-matched control subjects. The mean age of the DM2 patients was 58.12 +/- 13.39 years, with a mean duration of the diabetes of 5.40 +/- 4.32 years. The mean level of HbAlc of the DM2 patients was 8.93 +/- 2.56. Patients with DM2 showed a higher frequency of SCE compared with controls (7.11 +/- 1.14 and 4.96 +/- 0.92, p < 0.001). Furthermore, the SCE frequency was positively correlated with the plasma HbA1c level (p < 0.05), but there was no significant correlation between the duration of diabetes and SCE. On the other hand, our result showed a MN frequency significant increase in DM2 patients (3.45 +/- 1.01 per 1000 cells) relative to that of the control group (1.79 +/- 0.67 per 1000 cells) (p < 0.001), but there was no significant correlation between the duration of diabetes, HbA1c and MN. In conclusion, these results suggest that DM2 is a condition with genomic instability characterized by an increased level of SCE and MN. Hyperglycemia-induced oxidative stress may be the underlying factor of the increased SCE and MN frequency.
Insights
Type-2 diabetes mellitus (DM2) is linked to increased DNA damage, specifically higher frequencies of sister chromatid exchange (SCE) and micronuclei (MN). This genomic instability in DM2 patients may stem from hyperglycemia-induced oxidative stress.
Area of Science:
- Genetics
- Endocrinology
- Molecular Biology
Background:
- DNA damage is implicated in the pathogenesis of type-2 diabetes mellitus (DM2) and its complications.
- Various in vitro assays exist for measuring DNA damage.
Purpose of the Study:
- To investigate the frequency of sister chromatid exchange (SCE) and micronuclei (MN) in DM2 patients compared to healthy controls.
Main Methods:
- Blood cell cultures from 50 DM2 patients and 30 healthy controls were analyzed.
- Sister chromatid exchange (SCE) and micronuclei (MN) tests were performed.
- Demographic and clinical data, including HbA1c levels, were collected.
Main Results:
- DM2 patients exhibited significantly higher frequencies of SCE (7.11 +/- 1.14) compared to controls (4.96 +/- 0.92) (p < 0.001).
- SCE frequency positively correlated with HbA1c levels (p < 0.05) but not with diabetes duration.
- A significant increase in MN frequency was observed in DM2 patients (3.45 +/- 1.01 per 1000 cells) versus controls (1.79 +/- 0.67 per 1000 cells) (p < 0.001).
- No significant correlation was found between MN frequency and diabetes duration or HbA1c levels.
Conclusions:
- DM2 is characterized by genomic instability, evidenced by elevated SCE and MN frequencies.
- Hyperglycemia-induced oxidative stress is a potential underlying mechanism for increased DNA damage in DM2.
- These findings highlight the role of DNA damage in DM2 pathogenesis and complications.
Related Concept Videos
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis